Project Title: Intelligent microfluidic screen system to fabricate artificial pancreas for diabetes treatments

Over 400 million people worldwide suffer from diabetes and more than half a million are children below the age of 15 years. A pancreas transplant is a promising solution—placing a functional pancreas into a patient whose pancreas no longer functions properly. However, the amount and quality of available pancreases is limited. Although many artificial pancreases were previously developed by using hydrogels with encapsulated islets, the challenges of low islet encapsulation rate, and limited insulin production remained.

With our advanced AI-microfluidic screening system, a high-quality artificial pancreas with dense islet encapsulated can be fabricated for effective diabetic treatment.

Next
Next

ITF 2: Intelligent Combinational Cell Sorter